Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 20, 2009

Ontario Institute for Cancer Research to Use Helicos’ Single Molecule Sequencing Technology

  • The Ontario Institute for Cancer Research (OICR) has purchased the Helicos™ Genetic Analysis System to study cancer genomics. This single molecule sequencing technology reportedly enables scientists to various studies without DNA ligation or amplification.

    Helicos Biosciences says that genetic analysis with this platform eliminates the biases, complexity, and errors introduced by DNA amplification, requires minute amounts of starting material, and provides the most direct and accurate view of biological samples.

    “The translational cancer research we are conducting at our center can benefit greatly from the advantages of single molecule sequencing,” believes Tom Hudson, president and scientific director of the OICR. “We hope to use this technology for the unbiased and comprehensive characterization of tumor samples to ultimately lead to discoveries that have a clinical impact.”

     



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »